The present invention is directed to a compound represented by Structural Formula (I): or a pharmaceutically acceptable salt thereof. The variables for Structural Formula (I) are defined herein. Also described is a pharmaceutical composition comprising the compound of Structural Formula (I), or a pharmaceutically acceptable salt thereof, and its therapeutic use.
申请公布号
AU2013308504(A1)
申请公布日期
2015.04.02
申请号
AU20130308504
申请日期
2013.08.30
申请人
TETRAPHASE PHARMACEUTICALS, INC.
发明人
XIAO, XIAO-YI;CLARK, ROGER B.;HUNT, DIANA KATHARINE;SUN, CUIXIANG;RONN, MAGNUS;ZHANG, WU-YAN;HE, MINSHENG
